Mostrando 4 resultados de: 4
Área temáticas
Enfermedades(4)
Problemas sociales y servicios a grupos(3)
Farmacología y terapéutica(2)
Medicina y salud(2)
Origen
scopus(4)
CYP2D6 genotyping for psychiatric patients treated with risperidone: Considerations for cost-effectiveness studies
ArticleAbstract: In order to ascertain data availability and feasibility for conducting cost-effectiveness studies inPalabras claves:adverse drug reactions, Antipsychotic, cost-effectiveness, CYP2D6, polymorphisms, RisperidoneAutores:Adrián LLerena, De Leon J., de Mesa E.G., Gurwitz D., Ibarreta D., Kirchheiner J., Rodríguez-Antona C.Fuentes:scopusAn International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
ReviewAbstract: This international guideline proposes improving clozapine package inserts worldwide by using ancestrPalabras claves:American continental ancestry group, Asian continental ancestry group, clozapine/adverse effects, clozapine/blood, clozapine/metabolism, clozapine/therapeutic use, clozapine/toxicity, CYP1A2, drug labeling, European continental ancestry group, infection, inflammation, mortality/drug effects, Native, Sex, smoking.Autores:Adebayo R.A., Adrián LLerena, Anll Yaǧcloǧlu A.E., Arrojo-Romero M., Ayub M., Baptista T., Bebawi E., Bhattacharya R., Bilbily J., Bonelli R.M., Bousman C.A., Buckley P.F., Celofiga A., Chan S.K.W., Chopra N., Cohen D., Cotes R.O., Crespo-Facorro B., Cubała W.J., De Berardis D., De Las Cuevas C., De Leon J., Decloedt E., Eap C.B., Elkis H., Ertuǧrul A., Every-Palmer S., Farooq S., Fernandez-Egea E., Fountoulakis K.N., González-Esquivel D.F., Grover S., Gründer G., Hiemke C., Iglesias-Alonso A., Iglesias-Garcia C., Ignjatovic Ristic D., Jung-Cook H., Kaithi A.R., Kane J.M., Kelly D.L., Kim S.H., Kim Y.S., Kirilochev O.O., Kopeček M., Lana F., Lane H.Y., Lazary J., Leung J.G., Lin S.K., López-Jaramillo C., Marder S.R., Masmoudi R., McCollum B., McGrane I., Mohd Saffian S., Molden E., Motuca M., Ng C.H., Nielsen J., Olmos I., Ortiz B.B., Otsuka Y., Ouanes S., Pacheco Palha A.J., Pedro M.R., Procyshyn R.M., Quiles C., Rǎdulescu F., Rajkumar A.P., Ricciardi C., Rohde C., Ruan C.J., Sagud M., Sanz E.J., Schoretsanitis G., Schulte P.F.J., Seifritz E., Seppälä N., Shelton C., Silva A., Siskind D., Smith R.L., Solismaa A., Soloviev A., Spina E., Švancer P., Takeuchi H., Tang Y.L., Temmingh H., Torres R., Tsukahara M., Verdoux H., Villagrán-Moreno J.M., Wang C.Y., Wang G., Weizman A., Wilkowska A., Yecora A., Zolezzi M.Fuentes:scopusErratum: Schizophrenia and tobacco smoking in a Spanish psychiatric hospital (Schizophrenia Research (2002) 58 (323-327) PII: S09209964010032)
OtherAbstract:Palabras claves:Autores:Adrián LLerena, De la Rubia A., De Leon J., Diaz F.J., Penãs-Lledó E.M.Fuentes:scopusSchizophrenia and tobacco smoking in a Spanish psychiatric hospital
OtherAbstract: This study in a Spanish hospital replicated two US studies suggesting that schizophrenia is associatPalabras claves:antipsychotics, Logistics regression, Schizophrenia, smoking, tobaccoAutores:Adrián LLerena, De la Rubia A., De Leon J., Diaz F.J., Penãs-Lledó E.M.Fuentes:scopus